Literature DB >> 30227918

Persistence of NS5B-S282T, a sofosbuvir resistance-associated substitution, in a HIV/HCV-coinfected MSM with risk of onward transmission.

Astrid M Newsum1, Richard Molenkamp2, Jan T van der Meer3, Sjoerd P Rebers2, Maria Prins4, Marc van der Valk3, Janke Schinkel2.   

Abstract

Entities:  

Keywords:  Hepatitis C virus; Men who have sex with men; Resistance-associated substitution; S282T; Transmission

Mesh：

Substances：

Year:  2018        PMID： 30227918     DOI： 10.1016/j.jhep.2018.06.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance.

Authors:  Mark W Douglas; Enoch S E Tay; Dao Sen Wang; Adrian T L Ong; Caroline Wilson; Amy Phu; Jen Kok; Dominic E Dwyer; Rowena A Bull; Andrew R Lloyd; Tanya L Applegate; Gregory J Dore; Anita Y Howe; Richard Harrigan; Jacob George
Journal:  Hepatol Commun       Date:  2020-04-06

Review 2.  Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections.

Authors:  Rohan Janardhan Meshram; Gunderao Hanumantrao Kathwate; Rajesh Nivarti Gacche
Journal:  Arch Virol       Date:  2022-01-28       Impact factor: 2.685

Review 3.  Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges.

Authors:  Thomas F Baumert; Thomas Berg; Joseph K Lim; David R Nelson
Journal:  Gastroenterology       Date:  2018-10-17       Impact factor: 33.883

4.  HCV genome-wide analysis for development of efficient culture systems and unravelling of antiviral resistance in genotype 4.

Authors:  Long V Pham; Martin Schou Pedersen; Ulrik Fahnøe; Carlota Fernandez-Antunez; Daryl Humes; Kristian Schønning; Santseharay Ramirez; Jens Bukh
Journal:  Gut       Date:  2021-04-08       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.